Digital Content 
NEWS #PharmaBuzz
06 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/06/3075142/0/en/Moleculin-Announces-World-Health-Organization-Approval-of-naxtarubicin-as-International-Non-Proprietary-Name-for-Annamycin.html
05 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/05/3074063/0/en/Ascendis-to-Share-Its-Latest-Endocrinology-Rare-Disease-Data-at-ESPE-ESE-2025.html
29 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/29/3070231/0/en/Moleculin-Announces-New-Pre-Clinical-Data-for-Annamycin-Demonstrating-Market-Expansion-Potential-Including-Treatment-for-Pancreatic-Cancer.html
06 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moleculin-announces-additional-annamycin-patent-allowances-to-enhance-global-exclusivity-302393600.html
11 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/moleculin-receives-first-country-approval-in-europe-to-begin-recruiting-for-the-miracle-phase-3-rr-acute-myeloid-leukemia-aml-pivotal-trial-302372939.html
08 Jan 2025
// #N/A
https://www.prnewswire.com/news-releases/moleculin-highlights-development-progress-of-annamycin-phase-2-data-outperforms-billion-dollar-assets-in-aml-phase-3-data-readouts-in-2025--2026-302345069.html
Share 